Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial [0.03%]
司美格鲁肽治疗下肢动脉疾病的疗效与基线2型糖尿病特征的关系：STRIDE研究的启示
Neda Rasouli,Ecenur Guder Arslan,Andrei-Mircea Catarig et al.
Neda Rasouli et al.
Objective: The Semaglutide and Walking Capacity in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes (STRIDE) trial (NCT04560998) showed that once-weekly subcutaneous semaglutide 1.0 mg significantly i...
How to Fix a Broken Health Care System: Pathways to Maximize Health and Well-being for All [0.03%]
如何修复破碎的医疗体系：实现全民健康与福祉的最大化路径
Marshall H Chin,Joseph D Bruch,Colleen M Grogan et al.
Marshall H Chin et al.
The U.S. health care system is broken, with particularly low performance for health outcomes, access to care, equity, and administrative efficiency in comparison with other high-income countries, despite high cost. By virtue of the many ele...
Improving Affordability of Pharmaceutical Treatments for Diabetes: A Call for Action [0.03%]
改善糖尿病药物治疗的可负担性——行动呼吁
Mariana P Socal,Namratha R Kandula,Pineal I Bareamichael et al.
Mariana P Socal et al.
Unaffordability of pharmaceutical treatments remains as a critical barrier to diabetes care in the U.S. Through a synthesis of recent evidence on affordability of diabetes drugs, with particular attention to emergent reforms, this call for ...
Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in Diabetes Prevention Program (DPP) Outcomes Study (DPPOS) [0.03%]
糖尿病预防计划（DPP）结果研究（DPPOS）短期和长期随访的 sociodemographic、临床及心理社会预测因素
Ashley H Tjaden,Barbara H Braffett,Nicole M Butera et al.
Ashley H Tjaden et al.
Objective: Success of longitudinal studies depends on retention of participants. We examined characteristics as predictors of retention among participants with prediabetes and type 2 diabetes (T2D) in the Diabetes Prevent...
Mind the Gap: Discordance Between Cystatin C and Creatinine eGFR and Diabetes Complications [0.03%]
谨防差距：半胱氨酸C与肌酐估计肾小球滤过率不一致和糖尿病并发症之间的差异
Richard J MacIsaac
Richard J MacIsaac
Lutz Heinemann
Lutz Heinemann
The U.S. National Diabetes Prevention Program (NDPP) Shows Promise as a Cost-effective Implementation Strategy [0.03%]
美国糖尿病预防计划(NDPP)作为一种成本效益实施策略的前景展望
Ronald T Ackermann
Ronald T Ackermann
The Dilemma of Moderate Alcohol Consumption and Type 2 Diabetes Risk: Drinking Frequency Versus Quantity [0.03%]
适量饮酒与2型糖尿病风险的关系：饮酒频率 vs 饮酒量 dilemma
Cuiling Zhang,Taishun Li
Cuiling Zhang
Intersystem Accuracy in Continuous Glucose Monitoring: When Does This Matter? [0.03%]
连续葡萄糖监测的系统间一致性从何而来及其重要性如何？
Stephanie J Kim,Irl B Hirsch
Stephanie J Kim
Comment on Pasanisi et al. Metformin Treatment With or Without Mediterranean Diet for the Prevention of Age-Related Diseases in People With Metabolic Syndrome: The MeMeMe Randomized Trial. Diabetes Care 2025;48:265-272 [0.03%]
对Pasanisi等关于代谢综合征患者使用二甲双胍联合或不联合地中海饮食预防与年龄相关的疾病：MeMeMe随机试验的述评糖尿病护理 2025;48:265-272
Mayer B Davidson
Mayer B Davidson